17 research outputs found

    Angiotensin II receptor expression and relation to Helicobacter pylori-infection in the stomach of the Mongolian gerbil

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>The role of the renin-angiotensin system in gastric physiology and disease has as yet been sparsely explored. The first aim of the study was to investigate the baseline presence and location of angiotensin II receptors (AT1R and AT2R) in the stomach of the Mongolian gerbil. A second aim was to elucidate whether the presence of <it>H. pylori </it>infection is associated with changes in the expression of these receptors.</p> <p>Methods</p> <p><it>H. pylori</it>-negative and <it>H. pylori-</it>infected (strain SS1 or TN2GF4) male Mongolian gerbils were investigated. The stomachs were examined at six or 12 months after inoculation by the use of immunohistochemistry, western blot and microscopic morphometry.</p> <p>Results</p> <p>AT1R and AT2R were located in a variety of cells in the gerbil gastric wall, including a subpopulation of endocrine cells in the antral mucosa and inflammatory cells infiltrating <it>H. pylori</it>-infected stomachs. Gerbils infected with the SS1 strain showed a significantly increased antral AT1R protein expression and an increased number of infiltrating polymorphonuclear leucocytes (PMNs) at 12 months. The AT1R protein expression correlated with the number of PMNs and the antral expression of myeloperoxidase.</p> <p>Conclusions</p> <p>Angiotensin II receptors are present in a variety of cells in the gastric wall of the Mongolian gerbil. The results indicate an influence dependent on the <it>H. pylori </it>strain on the gastric AT1R expression and a relationship between gastric AT1R expression and mucosal PMNs infiltration.</p

    Impact of the upper gut on body fluid regulation and blood pressure in man - potential involvement of a locally expressed renin-angiotensin system

    Get PDF
    This thesis explores the role of the upper gut in the regulation of diuresis and blood pressure control in relation to the novel finding of a mucosa-located renin-angiotensin system (RAS). RAS is a regulatory super-system vital for body fluid homeostasis and blood pressure control. Recent research demonstrates that RAS is not only an endocrine (blood borne) system, but also in all respects locally expressed influencing tissue growth and differentiation as well as inflammatory responses. A first aim of the present thesis-project was to explore if RAS was expressed in the mucosa of the stomach and duodenum. Indeed, by use of western blot and immunohistochemistry most components of RAS were found in several compartments of the gastric mucosa of the Mongolian gerbil (model for human Helicobacter pylori infection) and also in the human mucosa. It was also observed that a subset of gastric mucosal endocrine cells expressed AT1 receptors suggesting that activity in a local RAS can influence enteroendocrine signalling. RAS components were found also in the mucosa of the human duodenum. The second aim of the thesis was to examine the potential functionality of the local mucosal RAS described above. The project was focussed on a previously described sodium/volume sensor postulated to be situated in upper gut. Such a sensor is activated by food ingestion/drinking and increases renal diuresis already in the pre-absorptive state. The upper-gut location of this regulatory principle was demonstrated in healthy volunteers by intragastric instillation of 750 ml saline that almost promptly was followed by an increased diuresis, whereas intrajejunal instillation had an additional 60 min lag-time until response. In a second set of experiments, the volunteer were first exposed to gastric instillation of saline (with sham-intubation as time control) and after 30 to 40 min a gastroduodenoscopy with sampling of mucosal biopsies was performed. The tissue specimens were examined for RAS components and the principal finding was that the concentration of the pro-hormone angiotensinogen decreased in the duodenal mucosa, but not in the stomach. The results confirm that a volume sensor is located to the upper gut in man. Furthermore, local mucosal RAS, particularly in the duodenum, may be involved in mediating the diuresis occurring in the pre-absorptive state after drinking and eating. The third aim of the project was related to the physiological and clinical relevance of the sodium/volume monitor described above. Patients participating in the Swedish Obese Subjects (SOS) study were investigated. Gastric bypass (GBP), meaning that food and drinks are led directly into the jejunum thus bypassing the major part of the stomach and duodenum, was compared to gastric band constructions. The latter type of weight reducing surgery restricts the food intake capacity with the alimentary route intact. Interestingly, after adjustments for weight loss the GBP patients exhibited a larger 24h diuresis and a markedly more reduced systolic and diastolic pressure than the gastric band patients. These changes were prominent also 10 years after surgical intervention and were not related to the reduced body weight. Furthermore, the GBP patients consumed, despite a lowered blood pressure, approximately 1 g dietary salt more per day than patients operated with the restrictive banding techniques. This picture is compatible with that the sodium/volume sensor induces diuresis in an anticipatory fashion in relation to ingestive load and also inhibits salt appetite. Upon removal of this pre-absorptive regulatory mechanisms (as following GBP), more rough post-absorptive regulatory principles dominate that very probably results in an overshooting diuretic effect with depressor action and an increased salt intake

    Diurnal urinary output after different types of bariatric surgery.

    No full text
    <p>Diurnal urinary output (U-Volume) in absolute values (upper panel) and in relation to body weight (lower panel) after gastric bypass surgery (GBP), after pure restrictive bariatric surgery (VBG/B) and in non-operated obese controls. Changes from baseline (Δ) at the 2 y and 10 y follow-up visits are displayed. Data are mean values adjusted for sex, age, baseline BMI and the baseline level of the respective variables. The bars represent the 95% confidence intervals. Differences between groups (upper panel) are given as mean (95% confidence intervals).*<i>P</i><0.01 and ***<i>P</i><0.001.</p

    Baseline characteristics of study subjects who completed follow-up after 2 y.

    No full text
    <p>Values are mean (±SD) unless otherwise stated. BMI, body mass index. GBP, gastric bypass surgery. VBG/B, pure restrictive bariatric surgery.</p>***<p><i>P</i><0.001,</p>**<p><i>P</i><0.01,</p>*<p><i>P</i><0.05 and ∧<i>P</i><0.10 using Students <i>t</i> test or Chi-square test.</p>¶<p>Daily salt intake was calculated by multiplying urinary sodium values by 0.0585 (molecular weight of NaCl: 58.5).</p

    Weight reduction independent changes from baseline after GBP and VBG/B at the 10 year follow up (multiple linear regression analyses).

    No full text
    a<p><b>:</b> Unadjusted difference between year 10 and baseline within each group. Minus signs denote reductions. Means (±SD) <sup>b</sup>Difference between year 10 and baseline within each group after adjustment for change in body mass index (BMI), sex, age, baseline BMI and the baseline level of the respective variables. Minus signs denote reductions. Mean values.</p>b<p><b>:</b> Difference between year 10 and baseline after adjustment for change in body mass index (BMI), sex, age, baseline BMI and the baseline level of the respective variables. Minus signs denote reductions. Mean values.</p>c<p>: Difference between gastric bypass surgery (GBP) and pure restrictive bariatric surgery (VBG/B) after adjustment for BMI change, sex, age, baseline BMI and the baseline level of the respective variables. Minus signs denote larger reductions in GBP compared to VBG/B group. Figures between brackets denote 95% confidence interval.</p>#<p>Daily salt intake was calculated by multiplying urinary sodium values by 0.0585 (molecular weight of NaCl: 58.5).</p>*<p>P<0.05,</p>**<p>P<0.01 and ***P<0.001 for test of difference between the GBP group and the VBG/B group in adjusted changes, using multiple linear regression.</p
    corecore